pLV.DsRed vector (V004915)

Basic Vector Information

Vector Name:
pLV.DsRed
Antibiotic Resistance:
Chloramphenicol
Length:
9186 bp
Type:
Shuttle vector
Replication origin:
ori
Source/Author:
Goncalves MA, de Vries AA, Holkers M, van de Watering MJ, van der Velde I, van Nierop GP, Valerio D, Knaan-Shanzer S.
Promoter:
EF-1α

pLV.DsRed vector Vector Map

pLV.DsRed9186 bp400800120016002000240028003200360040004400480052005600600064006800720076008000840088005' LTRHIV-1 PsiRREcPPT/CTSEF-1-alpha promoter5' LTR (truncated)T7 promoterDsRed-ExpressHIV-1 3' SIN LTRT3 promoterM13 revlac operatorlac promoterCAP binding siteoriCmRcat promoterAmpR promoterf1 oriM13 fwdT7 promoter

Plasmid Resuspension Protocol:

1. Centrifuge at 5,000×g for 5 min.

2. Carefully open the tube and add 20 μl of sterile water to dissolve the DNA.

3. Close the tube and incubate for 10 minutes at room temperature.

4. Briefly vortex the tube and then do a quick spin to concentrate the liquid at the bottom. Speed is less than 5000×g.

5.Store the plasmid at -20 ℃.

pLV.DsRed vector Sequence

Copy Sequence

Download GeneBank File(.gb)

LOCUS       40924_28886        9186 bp DNA     circular SYN 18-DEC-2018
DEFINITION  Shuttle vector pLV.DsRed, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 9186)
  AUTHORS   Goncalves MA, de Vries AA, Holkers M, van de Watering MJ, van der 
            Velde I, van Nierop GP, Valerio D, Knaan-Shanzer S.
  TITLE     Human mesenchymal stem cells ectopically expressing full-length 
            dystrophin can complement Duchenne muscular dystrophy myotubes by 
            cell fusion
  JOURNAL   Hum. Mol. Genet. 15 (2), 213-221 (2006)
  PUBMED    16321987
REFERENCE   2  (bases 1 to 9186)
  AUTHORS   Goncalves MA, Swildens J, Holkers M, Narain A, van Nierop GP, van de
            Watering MJ, Knaan-Shanzer S, de Vries AA.
  TITLE     Genetic complementation of human muscle cells via directed stem cell
            fusion
  JOURNAL   Mol. Ther. 16 (4), 741-748 (2008)
  PUBMED    18334989
REFERENCE   3  (bases 1 to 9186)
  AUTHORS   Goncalves MA, de Vries AA.
  TITLE     Direct Submission
  JOURNAL   Submitted (23-JUL-2007) Molecular Cell Biology, Leiden University 
            Medical Center, Einthovenweg 20, Leiden 2333 ZC, The Netherlands
REFERENCE   4  (bases 1 to 9186)
  TITLE     Direct Submission
REFERENCE   5  (bases 1 to 9186)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Hum. Mol. 
            Genet."; date: "2006"; volume: "15"; issue: "2"; pages: "213-221"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: "Mol. 
            Ther."; date: "2008"; volume: "16"; issue: "4"; pages: "741-748"
COMMENT     SGRef: number: 3; type: "Journal Article"; journalName: "Submitted 
            (23-JUL-2007) Molecular Cell Biology, Leiden University Medical 
            Center, Einthovenweg 20, Leiden 2333 ZC, The Netherlands"
COMMENT     SGRef: number: 4; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..9186
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     LTR             1..634
                     /label=5' LTR
                     /note="5' long terminal repeat (LTR) from HIV-1"
     misc_feature    681..808
                     /label=HIV-1 Psi
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     misc_feature    1459..1692
                     /label=RRE
                     /note="The Rev response element (RRE) of HIV-1 allows for 
                     Rev-dependent mRNA export from the nucleus to the 
                     cytoplasm."
     misc_feature    1789..1906
                     /label=cPPT/CTS
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     promoter        3196..4377
                     /label=EF-1-alpha promoter
                     /note="strong constitutive promoter for human elongation
                     factor EF-1-alpha"
     LTR             4485..4753
                     /label=5' LTR (truncated)
                     /note="truncated 5' long terminal repeat (LTR) from human
                     T-cell leukemia virus (HTLV) type 1"
     promoter        complement(4790..4808)
                     /label=T7 promoter
                     /note="promoter for bacteriophage T7 RNA polymerase"
     CDS             4900..5574
                     /codon_start=1
                     /label=DsRed-Express
                     /note="rapidly maturing tetrameric variant of DsRed
                     fluorescent protein (Bevis and Glick, 2002)"
                     /translation="MASSEDVIKEFMRFKVRMEGSVNGHEFEIEGEGEGRPYEGTQTAK
                     LKVTKGGPLPFAWDILSPQFQYGSKVYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGV
                     VTVTQDSSLQDGCFIYKVKFIGVNFPSDGPVMQKKTMGWEPSTERLYPRDGVLKGEIHK
                     ALKLKDGGHYLVEFKSIYMAKKPVQLPGYYYVDSKLDITSHNEDYTIVEQYERAEGRHH
                     LFL"
     repeat_region   5625..5859
                     /label=HIV-1 3' SIN LTR
                     /note="HIV-1 3' SIN LTR"
     LTR             5626..5858
                     /label=3' LTR (Delta-U3)
                     /note="self-inactivating 3' long terminal repeat (LTR) from
                     HIV-1"
     promoter        complement(5883..5901)
                     /label=T3 promoter
                     /note="promoter for bacteriophage T3 RNA polymerase"
     primer_bind     complement(5922..5938)
                     /label=M13 rev
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     protein_bind    complement(5946..5962)
                     /label=lac operator
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be 
                     relieved by adding lactose or 
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     promoter        complement(5970..6000)
                     /label=lac promoter
                     /note="promoter for the E. coli lac operon"
     protein_bind    complement(6015..6036)
                     /label=CAP binding site
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     rep_origin      complement(6324..6912)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(7304..7960)
                     /codon_start=1
                     /label=CmR
                     /note="chloramphenicol acetyltransferase"
                     /translation="MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFL
                     KTVKKNKHKFYPAFIHILARLMNAHPELRMAMKDGELVIWDSVHPCYTVFHEQTETFSS
                     LWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANM
                     DNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA"
     promoter        complement(7961..8063)
                     /label=cat promoter
                     /note="promoter of the E. coli cat gene encoding
                     chloramphenicol acetyltransferase"
     promoter        complement(8383..8487)
                     /label=AmpR promoter
     rep_origin      complement(8513..8968)
                     /direction=LEFT
                     /label=f1 ori
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"
     primer_bind     9110..9126
                     /label=M13 fwd
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     promoter        9136..9154
                     /label=T7 promoter
                     /note="promoter for bacteriophage T7 RNA polymerase"

This page is informational only.